Stock of the Day

Qiagen (QGEN)

$39.52

+$0.95 (+2.5%)

Market Cap: $8.56B

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Recent News

• Baird Downgrades Qiagen N.V. (QGEN) (msn.com)
• Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls (finance.yahoo.com)
• Optimistic Buy Rating for Qiagen: Market Position and Strategic Advancements Drive Growth Prospects (tipranks.com)
• Qiagen downgraded to Neutral from Outperform at Baird (markets.businessinsider.com)
• FFPE Tissue Samples for Genomics Study & Analysis Market to Cross US$ 1.5 Bn by 2034 with a Robust CAGR of 5.1%, Led by Key Players BioChain Institute, Amsbio, Cureline, Discovery Life Sciences, and QIAGEN - TMR (globenewswire.com)